How Rare Is 46,XX Testicular DSD? Prevalence Explained

46,XX testicular difference of sex development (DSD) is a condition where an individual has a 46,XX karyotype (typically associated with female development) but develops testicular tissue and male characteristics ^[1][2]. In older medical literature and records, it is sometimes referred to as “46,XX male syndrome” ^[3].

It is generally considered a rare condition. Medical literature estimates that it occurs in approximately 1 in 20,000 to 1 in 25,000 male live births ^[4][5]. A comprehensive registry study in Denmark found that the prevalence of diagnosed cases was between 3.5 and 4.7 per 100,000 newborn males (roughly 1 in 21,300 to 28,600) ^[6]. These numbers describe diagnosed populations and may miss individuals who remain undiagnosed ^[6]. Under definitions used in regions like the European Union, it clearly meets the numerical criteria for a rare disease ^[7].

Why It Often Goes Undiagnosed Until Adulthood

Many individuals born with 46,XX testicular DSD have typical male external genitalia, meaning there are no obvious physical signs to prompt a medical evaluation during childhood ^[6][8]. Because of this, it is common for the condition to go undiagnosed until adolescence or adulthood; one registry study found the median age of diagnosis was 17 years old ^[6]. (Note that this guide uses male terms when describing typical anatomy or historical literature, but individuals with this condition may identify across the gender spectrum).

The condition has a wide range of physical presentations depending on specific genetic factors, such as whether the SRY gene (a gene that typically directs male development) is present ^[1][9].

For many, the condition is discovered during medical evaluations for infertility—the inability to conceive after a year of regular, unprotected intercourse, though evaluation may happen sooner if there are known medical concerns ^[10][11]. These evaluations often reveal azoospermia (a complete absence of sperm in the semen), which prevents conception using one’s own sperm ^[6][10].

Other individuals may be diagnosed after noticing small testicular size, the development of gynecomastia (enlarged breast tissue), or symptoms of low testosterone during or after puberty ^[12][8]. Some may develop hypergonadotropic hypogonadism, a condition where the testicles produce very little testosterone despite high levels of pituitary gland hormones (like LH and FSH) signaling them to do so ^[6][10]. Importantly, hormone production and symptoms vary from person to person; experiencing them is not diagnostic on its own, and formal diagnosis requires chromosome and hormone testing ^[1][13].

Building Your Care Team

Because 46,XX testicular DSD is rare, your primary care doctor may not have experience with it. While local clinicians can coordinate routine care, experts recommend consulting with a specialized, multidisciplinary DSD team when available ^[14][15]. These teams often include ^[14][15][16]:

• Endocrinologists to assess your specific hormone levels, monitor bone health, and determine if individualized testosterone therapy is appropriate for you.
• Urologists to address physical anatomy, gonadal health, and sexual function (which is distinct from fertility).
• Geneticists to explain your exact karyotype, your SRY status, and what it means for your health.
• Psychologists to provide a safe space to process the emotional impact of the diagnosis, identity questions, or grief.
• Fertility specialists to evaluate your specific reproductive options and discuss alternative paths to parenthood, such as using donor sperm or adoption.

Having experienced specialists helps ensure that your care—whether monitoring hormone levels, checking gonadal health, or managing sexual function—is tailored to your unique biology and goals ^[14][15].